Peter Mueller, Director at BioXcel Therapeutics, Inc. (BTAI), bought 15,092 shares at $8.83 ($133K) on 2019-08-22, disclosed to the SEC on 2019-08-23.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.42 | 1,800 | $15K | 11.4% |
| 2 | $8.83 | 6,646 | $59K | 44.3% |
| 3 | $8.83 | 6,646 | $59K | 44.3% |
| Total | $8.78 avg | 15,092 | $133K | 100% |
| Filing → |
| BTAI | BUY | 2018-12-06 | $21K | — | Filing → |
| VRTX | SELL | 2014-06-18 | $512K | — | Filing → |
| VRTX | SELL | 2014-05-16 | $506K | — | Filing → |